Total Payments
$15,689
2024 Payments
$879.11
Companies
39
Transactions
348
Medicare Patients
21,410
Medicare Billing
$14.6M
Payment Breakdown by Category
Food & Beverage$7,823 (49.9%)
Other$7,247 (46.2%)
Travel$449.44 (2.9%)
Education$169.78 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,823 | 322 | 49.9% |
| Acquisitions | $4,157 | 1 | 26.5% |
| Current or prospective ownership or investment interest | $2,889 | 6 | 18.4% |
| Travel and Lodging | $449.44 | 2 | 2.9% |
| Education | $169.78 | 9 | 1.1% |
| Entertainment | $120.45 | 1 | 0.8% |
| Honoraria | $80.19 | 1 | 0.5% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
General
$15,689
342 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US Retina LLC | $7,046 | 13 | $0 (2022) |
| Genentech USA, Inc. | $1,214 | 73 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $951.79 | 32 | $0 (2024) |
| Allergan, Inc. | $890.37 | 32 | $0 (2022) |
| Alimera Sciences, Inc. | $763.39 | 42 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $461.69 | 20 | $0 (2021) |
| Abbott Laboratories | $449.44 | 2 | $0 (2023) |
| ABBVIE INC. | $410.41 | 14 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $327.61 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $304.01 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $879.11 | 28 | Regeneron Healthcare Solutions, Inc. ($232.73) |
| 2023 | $1,662 | 42 | Abbott Laboratories ($449.44) |
| 2022 | $6,832 | 54 | US Retina LLC ($5,321) |
| 2021 | $1,403 | 36 | US Retina LLC ($732.12) |
| 2020 | $1,029 | 42 | US Retina LLC ($361.14) |
| 2019 | $2,094 | 63 | US Retina LLC ($631.67) |
| 2018 | $726.67 | 37 | Allergan Inc. ($288.67) |
| 2017 | $1,062 | 46 | Allergan Inc. ($171.59) |
All Payment Transactions
348 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: EYE CARE | ||||||
| 12/17/2024 | Optos, Inc. | NFC-700 (Device), PANORAMIC OPHTHALMOSCOPE, OCT OPHTHALMOSCOPE | Entertainment | In-kind items and services | $120.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/12/2024 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/29/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: EYE CARE | ||||||
| 10/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/02/2024 | Notal Vision, Inc. | Foresee Home (Device) | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: Ophthalmology | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $32.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Ophthalmology | ||||||
| 09/04/2024 | ABBVIE INC. | OZURDEX (Drug), VUITY | Food and Beverage | In-kind items and services | $119.68 | General |
| Category: EYE CARE | ||||||
| 08/21/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: EYE CARE | ||||||
| 08/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/16/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: OPTOMETRY | ||||||
| 07/09/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 06/27/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 05/08/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Ophthalmology | ||||||
| 04/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $49.63 | General |
| Category: Ophthalmology | ||||||
| 04/10/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 04/04/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: EYE CARE | ||||||
| 04/03/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 5,050 | 16,441 | $10.0M | $3.6M |
| 2022 | 21 | 5,602 | 18,882 | $9.4M | $3.4M |
| 2021 | 19 | 5,542 | 21,449 | $9.3M | $3.6M |
| 2020 | 15 | 5,216 | 21,392 | $9.4M | $3.9M |
Total Patients
21,410
Total Services
78,164
Medicare Billing
$14.6M
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 198 | 2,776 | $4.2M | $1.9M | 45.7% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 139 | 2,807 | $1.4M | $606,668 | 43.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 112 | 1,764 | $882,000 | $321,623 | 36.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 412 | 1,963 | $1.8M | $182,802 | 10.4% |
| J3490 | Unclassified drugs | Office | 2023 | 26 | 90 | $226,400 | $159,017 | 70.2% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 23 | 720 | $126,000 | $86,660 | 68.8% |
| 92134 | Imaging of retina | Office | 2023 | 1,010 | 2,512 | $213,520 | $68,979 | 32.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 475 | 528 | $132,000 | $49,622 | 37.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 485 | 515 | $119,315 | $42,328 | 35.5% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 20 | 259 | $77,959 | $39,171 | 50.2% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 34 | 43 | $295,410 | $37,519 | 12.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 444 | 515 | $84,388 | $25,918 | 30.7% |
| 92250 | Photography of the retina | Office | 2023 | 746 | 923 | $138,865 | $21,880 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 306 | 335 | $59,382 | $18,475 | 31.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 163 | 163 | $45,006 | $16,402 | 36.4% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 11 | 14 | $64,120 | $11,708 | 18.3% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 12 | 14 | $69,720 | $9,462 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 65 | $16,400 | $5,679 | 34.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 84 | 84 | $16,212 | $5,303 | 32.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 121 | 127 | $8,382 | $5,216 | 62.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $7,410 | $4,462 | 60.2% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 74 | 74 | $8,510 | $3,965 | 46.6% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 13 | 14 | $21,000 | $2,523 | 12.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 18 | 48 | $7,479 | $2,452 | 32.8% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 49 | $4,704 | $2,296 | 48.8% |
About Dr. Daniel Alfaro, M.D
Dr. Daniel Alfaro, M.D is a Ophthalmology healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982719290.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Alfaro, M.D has received a total of $15,689 in payments from pharmaceutical and medical device companies, with $879.11 received in 2024. These payments were reported across 348 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,823).
As a Medicare-enrolled provider, Alfaro has provided services to 21,410 Medicare beneficiaries, totaling 78,164 services with total Medicare billing of $14.6M. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Charleston, SC
- Active Since 08/20/2006
- Last Updated 04/19/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1982719290
Products in Payments
- OZURDEX (Drug) $1,167
- Lucentis (Biological) $796.79
- EYLEA (Biological) $597.12
- ILUVIEN (Drug) $449.81
- AVEIR (Device) $449.44
- YUTIQ (Drug) $344.99
- LOTEMAX SM (Drug) $337.44
- ACTHAR (Biological) $260.72
- Vabysmo (Drug) $253.29
- VABYSMO (Drug) $244.42
- Cimerli (Biological) $230.21
- EYLEA HD (Biological) $225.54
- Iluvien (Drug) $213.87
- INVELTYS (Drug) $187.22
- XIIDRA (Drug) $161.78
- LOTEMAX GEL (Drug) $135.42
- EYLEA AFLIBERCEPT INJECTION (Biological) $129.13
- NFC-700 (Device) $120.45
- Rhopressa (Drug) $111.52
- Izervay (Drug) $89.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Charleston
Aljoeson Walker, Md, MD
Ophthalmology — Payments: $87,715
Ophthalmology $87,715
M Wilson, Md, MD
Ophthalmology — Payments: $21,002
Ophthalmology $21,002
Dr. Edward Trudo, M.d, M.D
Ophthalmology — Payments: $18,586
Ophthalmology $18,586
Galin Spicer, Md, MD
Ophthalmology — Payments: $14,618
Ophthalmology $14,618
Dr. Matthew Nutaitis, M.d, M.D
Ophthalmology — Payments: $13,896
Ophthalmology $13,896
John Kerrison, M.d, M.D
Ophthalmology — Payments: $12,316
Ophthalmology $12,316